Related Experiment Video
Updated: Aug 11, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Enhanced inactivation of prostaglandin E2 by the rabbit lung during pregnancy or progesterone treatment
Abstract:
1. The inactivation of prostaglandin E2 by the rabbit lung was estimated in vivo by comparing its depressor potency following intravenous and intra-aortic injections, and in vitro by measuring the rate of disappearance of smooth muscle stimulating activity when the prostaglandin was incubated with high speed supernatant fractions from lung homogenates. 2. The ability of the lung to inactivate prostaglandin E2 in vivo increased gradually throughout pregnancy, and then decreased rapidly during the three days post-partum. 3. An increased lung inactivation was also seen in pseudopregnant (day 12) rabbits, and in non-pregnant rabbits treated with progesterone for 12 days. A further increase occurred when progesterone treatment was prolonged to 26 days. 4. Treatment with oestradiol monobenzoate or cortisol for 12 days, and deprivation of ovarian hormones for 14-17 days by ovariectomy, were without effect on the lung inactivation of prostaglandin E2. 5. The in vitro experiments revealed a striking increased in the activity of lung prostaglandin metabolizing enzymes during pregnancy. 6. The results are discussed in relation to the hormonal changes occurring during pregnancy, and it is suggested than an enhanced lung inactivation of prostaglandins might have an important protective function at this time.
More Related Videos
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

